Published in Pharma Investments, Ventures and Law Weekly, February 26th, 2006
This income tax charge of approximately 7 cents per share was associated with the repatriation of $103 million of accumulated foreign earnings under the American Jobs Creation Act. Full-year earnings on the same basis were $1.94/diluted share, a 27.6% increase over full-year 2004. Generally accepted accounting principles earnings for the fourth quarter ended December 31, 2005 were $0.47/diluted share and full-year earnings were $1.88/diluted share.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.